Research Article
Caulis Sargentodoxae Prescription Plays a Therapeutic Role with Decreased Inflammatory Cytokines in Peritoneal Fluid in the Rat Endometriosis Model
Table 4
The content of IL-1, IL-2, IL-6, and TNF-
α in the peritoneal fluid after treatment
.
| Group | N | IL-1 (ng/L) | IL-2 (ng/L) | IL-6 (pg/ml) | TNF-α (ng/L) |
| Normal control | 5 | 126.96 ± 15.34 | 993.98 ± 101.44 | 62.13 ± 12.42 | 220.80 ± 24.24 | Model | 8 | 228.80 ± 15.39☆ | 2132.55 ± 99.41☆ | 143.42 ± 7.62☆ | 511.78 ± 18.45☆ | Ovariectomized | 8 | 156.15 ± 32.29 | 1365.05 ± 398.65 | 111.38 ± 23.37 | 263.47 ± 48.45 | Gestrinone | 7 | 159.96 ± 21.22 | 1606.71 ± 200.78 | 95.43 ± 8.92 | 308.22 ± 17.88 | Caulis Sargentodoxae prescription | 8 | 130.30 ± 19.32 | 1356.89 ± 279.98 | 108.27 ± 15.45 | 356.01 ± 47.73 | Celecoxib | 7 | 147.52 ± 25.35 | 1342.12 ± 107.68 | 111.25 ± 19.78 | 309.57 ± 38.81 | Combination | 7 | 128.75 ± 24.85 | 1168.52 ± 194.83 | 91.43 ± 15.70 | 274.11 ± 31.82 | F | — | 8.529 | 8.118 | 9.102 | 28.595 | | — | 0.001 | <0.001 | 0.001 | <0.001 |
|
|
, compared with the model group. ☆ expresses , compared with the normal control group. |